Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

An exon skipping screen identifies antitumor drugs that are potent modulators of pre-mRNA splicing, suggesting new therapeutic applications

PLoS ONE(2020)10.1371/journal.pone.0233672Source: DataRank Database

An exon skipping screen identifies antitumor drugs that are potent modulators of pre-mRNA splicing, suggesting new therapeutic applications is a research paper published in PLoS ONE (2020). On theSindex it has a DataRank of 0. It has been cited 21 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.75)OA: goldTopics (35)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Walter M. Bray ORCID,Alexander J. Smith ORCID,Wei Zhou ORCID,Joy M. Calaoagan,Chandraiah Lagisetti

Live enrichment

PubMed:32469945 PMC:PMC7259758 OpenAlex:https://openalex.org/W3032515989

National Institutes of Health

Grant: CA2147590

FWCI

0.75

Citation Percentile

0.7%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0233672&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0233672&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0233672

journalhttps://doi.org/10.1371/journal.pone.0233672

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32469945

Fields of Study

RNA modifications and cancerRNA Research and SplicingProtein Degradation and InhibitorsAntineoplastic AgentsCell Line, TumorDrug Screening Assays, AntitumorExonsHumansNeoplasmsProtein Kinase InhibitorsRNA PrecursorsRNA Splicing

MeSH Terms

Antineoplastic AgentsDrug Screening Assays, AntitumorExonsHumansNeoplasmsRNA PrecursorsRNA SplicingCell Line, TumorProtein Kinase Inhibitors

Keywords

SpliceosomeExon skippingRNA splicingExonDrug discoveryAlternative splicingComputational biologyBiologyPharmacologyCancer researchBioinformaticsGeneticsGeneRNA

Sustainable Development Goals

SDG 0: Good health and well-being